Demand for pain management devices will increase through 2036, with neurostimulation devices at a 48.0% share of the leading product segment in 2026. The market is valued at USD 7.7 billion in 2026 and is forecast to reach USD 13.5 billion by 2036 as chronic pain interventions expand.